These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25480636)

  • 41. Systems biology of megakaryocytes.
    Kaushansky A; Kaushansky K
    Adv Exp Med Biol; 2014; 844():59-84. PubMed ID: 25480637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of molecular basis of iron metabolism regulation and the associated pathologies.
    Silva B; Faustino P
    Biochim Biophys Acta; 2015 Jul; 1852(7):1347-59. PubMed ID: 25843914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythropoiesis and transferrin receptors.
    Moura IC; Hermine O; Lacombe C; Mayeux P
    Curr Opin Hematol; 2015 May; 22(3):193-8. PubMed ID: 25767952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors.
    Xiang J; Wu DC; Chen Y; Paulson RF
    Blood; 2015 Mar; 125(11):1803-12. PubMed ID: 25608563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insights into iron regulation and erythropoiesis.
    Kim A; Nemeth E
    Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human and murine erythropoiesis.
    An X; Schulz VP; Mohandas N; Gallagher PG
    Curr Opin Hematol; 2015 May; 22(3):206-11. PubMed ID: 25719574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
    Palmer SC; Saglimbene V; Mavridis D; Salanti G; Craig JC; Tonelli M; Wiebe N; Strippoli GF
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010590. PubMed ID: 25486075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heme oxygenase-1 deficiency alters erythroblastic island formation, steady-state erythropoiesis and red blood cell lifespan in mice.
    Fraser ST; Midwinter RG; Coupland LA; Kong S; Berger BS; Yeo JH; Andrade OC; Cromer D; Suarna C; Lam M; Maghzal GJ; Chong BH; Parish CR; Stocker R
    Haematologica; 2015 May; 100(5):601-10. PubMed ID: 25682599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of cell differentiation by Eph receptor and ephrin signaling.
    Wilkinson DG
    Cell Adh Migr; 2014; 8(4):339-48. PubMed ID: 25482623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.
    Javan H; Szucsik AM; Li L; Schaaf CL; Salama ME; Selzman CH
    Circ Heart Fail; 2015 Jan; 8(1):109-18. PubMed ID: 25480781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability.
    Chung J; Bauer DE; Ghamari A; Nizzi CP; Deck KM; Kingsley PD; Yien YY; Huston NC; Chen C; Schultz IJ; Dalton AJ; Wittig JG; Palis J; Orkin SH; Lodish HF; Eisenstein RS; Cantor AB; Paw BH
    Sci Signal; 2015 Apr; 8(372):ra34. PubMed ID: 25872869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and differentiation of the erythroid lineage in mammals.
    Barminko J; Reinholt B; Baron MH
    Dev Comp Immunol; 2016 May; 58():18-29. PubMed ID: 26709231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
    Lang E; Lang F
    Biomed Res Int; 2015; 2015():513518. PubMed ID: 25821808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain.
    Suzuki N; Mukai HY; Yamamoto M
    PLoS One; 2015; 10(3):e0119442. PubMed ID: 25790231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythropoietin gene expression: developmental-stage specificity, cell-type specificity, and hypoxia inducibility.
    Suzuki N
    Tohoku J Exp Med; 2015 Mar; 235(3):233-40. PubMed ID: 25786542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anemia: progress in molecular mechanisms and therapies.
    Sankaran VG; Weiss MJ
    Nat Med; 2015 Mar; 21(3):221-30. PubMed ID: 25742458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin.
    Collino M; Thiemermann C; Cerami A; Brines M
    Pharmacol Ther; 2015 Jul; 151():32-40. PubMed ID: 25728128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autophagy as a regulatory component of erythropoiesis.
    Zhang J; Wu K; Xiao X; Liao J; Hu Q; Chen H; Liu J; An X
    Int J Mol Sci; 2015 Feb; 16(2):4083-94. PubMed ID: 25689426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide association study follow-up identifies cyclin A2 as a regulator of the transition through cytokinesis during terminal erythropoiesis.
    Ludwig LS; Cho H; Wakabayashi A; Eng JC; Ulirsch JC; Fleming MD; Lodish HF; Sankaran VG
    Am J Hematol; 2015 May; 90(5):386-91. PubMed ID: 25615569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematopoietic development at high altitude: blood stem cells put to the test.
    Zovein AC; Forsberg EC
    Development; 2015 May; 142(10):1728-32. PubMed ID: 25968308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.